Skip to main content
Erschienen in: World Journal of Surgery 2/2020

30.09.2019 | Original Scientific Report

Effects of Social Disparities on Management and Surgical Outcomes for Patients with Secondary Hyperparathyroidism

verfasst von: Brittany Greene, S. Joseph Kim, Ellen P. McCarthy, Jesse D. Pasternak

Erschienen in: World Journal of Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Nearly 80% of chronic renal failure patients have secondary hyperparathyroidism. Cinacalcet is used to lower parathyroid hormone; however, it is expensive and has side effects. When secondary hyperparathyroidism is resistant to medication or medications are inaccessible, parathyroidectomy is performed. Race and socioeconomic status influence access to care and surgical outcomes. We sought to evaluate the effect of race and socioeconomic status on parathyroidectomy rate as well as surgical outcomes of patients with secondary hyperparathyroidism.

Methods

We undertook cross-sectional analysis of adults diagnosed with secondary hyperparathyroidism in the USA between 2012 and 2014, using the National Inpatient Sample. Univariate and multivariate analyses were used to determine associations between social disparities, likelihood to undergo parathyroidectomy, and surgical outcomes.

Results

Between 2012 and 2014, a national estimate of 724,170 hospitalizations were identified where patients had a diagnosis of secondary hyperparathyroidism. Operative rate was 0.67%. By socioeconomic status, differences in rates of surgery in the poorest compared to the richest were not significant (0.74% vs. 0.55%, OR 1.08, p = 0.5). African-American patients had higher rates of parathyroidectomy compared to Caucasians (1 vs. 0.74%, OR 1.49, p < 0.001). African-American patients also had a trend toward more complications and greater length of stay.

Conclusions

According to a large administrative dataset, parathyroidectomy for secondary hyperparathyroidism is seldom used in the USA. African-American patients have higher rates of surgical management. Surgical outcomes may be affected by race. Clinicians treating secondary hyperparathyroidism should be aware of existing disparities within their health system.
Literatur
1.
Zurück zum Zitat Owda A, Elhwairis H, Narra S et al (2009) Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race. Renal Fail 25:595–602CrossRef Owda A, Elhwairis H, Narra S et al (2009) Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race. Renal Fail 25:595–602CrossRef
2.
Zurück zum Zitat Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913–921CrossRef Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913–921CrossRef
3.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes CKD-MBD Work Group (2009) Kdigo clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (ckd-mbd). Kidney Int Suppl 113:S1–S130 Kidney Disease: Improving Global Outcomes CKD-MBD Work Group (2009) Kdigo clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (ckd-mbd). Kidney Int Suppl 113:S1–S130
4.
Zurück zum Zitat Ketteler M, Block GA, Evenepoel P et al (2018) Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med 168:422–430CrossRef Ketteler M, Block GA, Evenepoel P et al (2018) Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med 168:422–430CrossRef
5.
Zurück zum Zitat Lee A, Song X, Khan I et al (2011) Association of cinacalcet adherence and costs in patients on dialysis. J Med Econ 14:798–804CrossRef Lee A, Song X, Khan I et al (2011) Association of cinacalcet adherence and costs in patients on dialysis. J Med Econ 14:798–804CrossRef
6.
Zurück zum Zitat Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525CrossRef Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525CrossRef
7.
Zurück zum Zitat Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482–2494CrossRef Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482–2494CrossRef
8.
Zurück zum Zitat Li J, Cornacchi SD, Farrokhyar F et al (2019) Relation between socioeconomic variables and surgical, systemic and radiation treatment in a cohort of patients with breast cancer in an Urban Canadian Centre. Can J Surg 62:83–92CrossRef Li J, Cornacchi SD, Farrokhyar F et al (2019) Relation between socioeconomic variables and surgical, systemic and radiation treatment in a cohort of patients with breast cancer in an Urban Canadian Centre. Can J Surg 62:83–92CrossRef
9.
Zurück zum Zitat Liu JH, Zingmond DS, McGory ML et al (2006) Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 296:1973–1980CrossRef Liu JH, Zingmond DS, McGory ML et al (2006) Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 296:1973–1980CrossRef
10.
Zurück zum Zitat Rothenberg BM, Pearson T, Zwanziger J et al (2004) Explaining disparities in access to high-quality cardiac surgeons. Ann Thorac Surg 78:18–24 (discussion 24-15)CrossRef Rothenberg BM, Pearson T, Zwanziger J et al (2004) Explaining disparities in access to high-quality cardiac surgeons. Ann Thorac Surg 78:18–24 (discussion 24-15)CrossRef
11.
Zurück zum Zitat Al-Qurayshi Z, Randolph GW, Srivastav S et al (2016) Outcomes in endocrine cancer surgery are affected by racial, economic, and healthcare system demographics. Laryngoscope 126:775–781CrossRef Al-Qurayshi Z, Randolph GW, Srivastav S et al (2016) Outcomes in endocrine cancer surgery are affected by racial, economic, and healthcare system demographics. Laryngoscope 126:775–781CrossRef
12.
Zurück zum Zitat Noureldine SI, Abbas A, Tufano RP et al (2014) The impact of surgical volume on racial disparity in thyroid and parathyroid surgery. Ann Surg Oncol 21:2733–2739CrossRef Noureldine SI, Abbas A, Tufano RP et al (2014) The impact of surgical volume on racial disparity in thyroid and parathyroid surgery. Ann Surg Oncol 21:2733–2739CrossRef
13.
Zurück zum Zitat Eidman KE, Wetmore JB (2017) The role of parathyroidectomy in the management of secondary hyperparathyroidism. Curr Opin Nephrol Hypertens 26:516–522CrossRef Eidman KE, Wetmore JB (2017) The role of parathyroidectomy in the management of secondary hyperparathyroidism. Curr Opin Nephrol Hypertens 26:516–522CrossRef
14.
Zurück zum Zitat Kim SM, Long J, Montez-Rath ME et al (2016) Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the united states. Clin J Am Soc Nephrol 11:1260–1267CrossRef Kim SM, Long J, Montez-Rath ME et al (2016) Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the united states. Clin J Am Soc Nephrol 11:1260–1267CrossRef
15.
Zurück zum Zitat Li S, Chen YW, Peng Y et al (2011) Trends in parathyroidectomy rates in us hemodialysis patients from 1992 to 2007. American journal of kidney diseases. Off J Natl Kidney Found 57:602–611CrossRef Li S, Chen YW, Peng Y et al (2011) Trends in parathyroidectomy rates in us hemodialysis patients from 1992 to 2007. American journal of kidney diseases. Off J Natl Kidney Found 57:602–611CrossRef
16.
Zurück zum Zitat Hcup national inpatient sample (nis). Healthcare cost and utilization project (hcup)., Rockville, MD, Agency for Healthcare Research and Quality, 2012–2014 Hcup national inpatient sample (nis). Healthcare cost and utilization project (hcup)., Rockville, MD, Agency for Healthcare Research and Quality, 2012–2014
17.
Zurück zum Zitat Rroji M, Spasovski G (2018) Calcimimetics versus parathyroidectomy: What is preferable? Int Urol Nephrol 50:1271–1275CrossRef Rroji M, Spasovski G (2018) Calcimimetics versus parathyroidectomy: What is preferable? Int Urol Nephrol 50:1271–1275CrossRef
18.
Zurück zum Zitat Sharma J, Raggi P, Kutner N et al (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am College Surg 214:400–407 (discussion 407–408)CrossRef Sharma J, Raggi P, Kutner N et al (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am College Surg 214:400–407 (discussion 407–408)CrossRef
19.
Zurück zum Zitat Conzo G, Perna AF, Savica V et al (2013) Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era. BMC Surg 13 Suppl 2:S4CrossRef Conzo G, Perna AF, Savica V et al (2013) Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era. BMC Surg 13 Suppl 2:S4CrossRef
20.
Zurück zum Zitat Apetrii M, Goldsmith D, Nistor I et al (2017) Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (ckd-mbd)—a systematic review and meta-analysis. PLoS ONE 12:e0187025CrossRef Apetrii M, Goldsmith D, Nistor I et al (2017) Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (ckd-mbd)—a systematic review and meta-analysis. PLoS ONE 12:e0187025CrossRef
21.
Zurück zum Zitat van der Plas WY, Dulfer RR, Engelsman AF et al (2017) Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review. Nephrol Dial Transpl 32:1902–1908CrossRef van der Plas WY, Dulfer RR, Engelsman AF et al (2017) Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review. Nephrol Dial Transpl 32:1902–1908CrossRef
22.
Zurück zum Zitat Kilpatrick RD, Newsome BB, Zaun D et al (2013) Evaluating real-world use of cinacalcet and biochemical response to therapy in us hemodialysis patients. Am J Nephrol 37:389–398CrossRef Kilpatrick RD, Newsome BB, Zaun D et al (2013) Evaluating real-world use of cinacalcet and biochemical response to therapy in us hemodialysis patients. Am J Nephrol 37:389–398CrossRef
23.
Zurück zum Zitat Kim JJ, Basu M, Plantinga L et al (2018) Awareness of racial disparities in kidney transplantation among health care providers in dialysis facilities. Clin J Am Soc Nephrol 13:772–781CrossRef Kim JJ, Basu M, Plantinga L et al (2018) Awareness of racial disparities in kidney transplantation among health care providers in dialysis facilities. Clin J Am Soc Nephrol 13:772–781CrossRef
24.
Zurück zum Zitat Joshi S, Gaynor JJ, Bayers S et al (2013) Disparities among blacks, hispanics, and whites in time from starting dialysis to kidney transplant waitlisting. Transplantation 95:309–318CrossRef Joshi S, Gaynor JJ, Bayers S et al (2013) Disparities among blacks, hispanics, and whites in time from starting dialysis to kidney transplant waitlisting. Transplantation 95:309–318CrossRef
25.
Zurück zum Zitat Saunders MR, Lee H, Alexander GC et al (2015) Racial disparities in reaching the renal transplant waitlist: Is geography as important as race? Clin Transplant 29:531–538CrossRef Saunders MR, Lee H, Alexander GC et al (2015) Racial disparities in reaching the renal transplant waitlist: Is geography as important as race? Clin Transplant 29:531–538CrossRef
26.
Zurück zum Zitat Fuller DS, Xing S, Belozeroff V et al (2019) Variability in cinacalcet prescription across us hemodialysis facilities. Clin J Am Soc Nephrol 14:241–249CrossRef Fuller DS, Xing S, Belozeroff V et al (2019) Variability in cinacalcet prescription across us hemodialysis facilities. Clin J Am Soc Nephrol 14:241–249CrossRef
27.
Zurück zum Zitat Saran R, Robinson B, Abbott KC et al (2018) Us renal data system 2017 annual data report: Epidemiology of kidney disease in the united states. Am J Kidney Dis Off J Natl Kidney Found 71:A7CrossRef Saran R, Robinson B, Abbott KC et al (2018) Us renal data system 2017 annual data report: Epidemiology of kidney disease in the united states. Am J Kidney Dis Off J Natl Kidney Found 71:A7CrossRef
28.
Zurück zum Zitat Padula WV, Ballreich J, Anderson GF (2018) Paying for drugs after the medicare part d beneficiary reaches the catastrophic limit: lessons on cost sharing from other us policy partnerships between government and commercial industry. Appl Health Econ Health Policy 16:753–763CrossRef Padula WV, Ballreich J, Anderson GF (2018) Paying for drugs after the medicare part d beneficiary reaches the catastrophic limit: lessons on cost sharing from other us policy partnerships between government and commercial industry. Appl Health Econ Health Policy 16:753–763CrossRef
29.
Zurück zum Zitat Reams BD, Dluzniewski PJ, Do TP et al (2015) Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective new-user cohort design. BMC Nephrol 16:175CrossRef Reams BD, Dluzniewski PJ, Do TP et al (2015) Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective new-user cohort design. BMC Nephrol 16:175CrossRef
30.
Zurück zum Zitat Turenne MN, Cope EL, Porenta S et al (2015) Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management? J Am Soc Nephrol 26:754–764CrossRef Turenne MN, Cope EL, Porenta S et al (2015) Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management? J Am Soc Nephrol 26:754–764CrossRef
31.
Zurück zum Zitat Spoendlin J, Schneeweiss S, Tsacogianis T et al (2018) Association of medicare's bundled payment reform with changes in use of vitamin d among patients receiving maintenance hemodialysis: an interrupted time-series analysis. Am J Kidney Dis Off J Natl Kidney Found 72:178–187CrossRef Spoendlin J, Schneeweiss S, Tsacogianis T et al (2018) Association of medicare's bundled payment reform with changes in use of vitamin d among patients receiving maintenance hemodialysis: an interrupted time-series analysis. Am J Kidney Dis Off J Natl Kidney Found 72:178–187CrossRef
32.
Zurück zum Zitat Boer R, Lalla AM, Belozeroff V (2012) Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States. J Med Econ 15:509–520CrossRef Boer R, Lalla AM, Belozeroff V (2012) Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States. J Med Econ 15:509–520CrossRef
33.
Zurück zum Zitat Hauch A, Al-Qurayshi Z, Kandil E (2015) The effect of race and socioeconomic status on outcomes following adrenal operations. J Surg Oncol 112:822–827CrossRef Hauch A, Al-Qurayshi Z, Kandil E (2015) The effect of race and socioeconomic status on outcomes following adrenal operations. J Surg Oncol 112:822–827CrossRef
Metadaten
Titel
Effects of Social Disparities on Management and Surgical Outcomes for Patients with Secondary Hyperparathyroidism
verfasst von
Brittany Greene
S. Joseph Kim
Ellen P. McCarthy
Jesse D. Pasternak
Publikationsdatum
30.09.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 2/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05207-4

Weitere Artikel der Ausgabe 2/2020

World Journal of Surgery 2/2020 Zur Ausgabe

Presidential Address

Mastery in Endocrine Surgery

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.